Table 1.
AF (n = 183) |
Non-AF (n = 107) |
p Value | |
---|---|---|---|
Age onset, y | 53.9 ± 11.6 | 45.4 ± 16.5 | <0.001 * |
Age at admission, y | 58.5 ± 11.0 | 50.5 ± 15.1 | <0.001 * |
Female, n (%) | 57 (31.1) | 57 (53.3) | 0.001 * |
BMI, kg/m2 | 25.8 ± 3.6 | 25.0 ± 3.5 | 0.059 |
Comorbidities, n (%) | |||
Hypertension | 95 (51.9) | 35 (32.7) | 0.002 * |
Diabetes mellitus | 36 (19.7) | 18 (16.8) | 0.547 |
Coronary heart disease | 31 (16.9) | 13 (12.1) | 0.273 |
Heart failure | 25 (13.7) | 4 (3.7) | 0.007 * |
Stroke | 24 (13.1) | 7 (6.5) | 0.080 |
Vascular disease | 19 (10.4) | 5 (4.7) | 0.089 |
CHA2DS2-VASc score | 2.0 ± 1.5 | - | - |
HAS-BLED score | 0.6 ± 0.7 | - | - |
Open heart surgery, n (%) | 7 (3.8) | 2 (1.9) | 0.354 |
NYHA-FC, n (%) | |||
I/II | 177 (96.7) | 107 (100.0) | 0.058 |
III/IV | 6 (3.3) | 0 | 0.058 |
LAV, mL | 68.2 ± 25.8 | 49.7 ± 18.1 | <0.001 * |
LVEF, % | 62.3 ± 7.0 | 64.0 ± 5.3 | 0.023 * |
BMI = body mass index; LAV = left atrial volume; LVEF = left ventricular ejection fraction; NYHA-FC = New York Heart Association functional class. * Variables with p value < 0.05.